Literature DB >> 24356810

Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.

Akira Mukai1, Hideki Iijima, Satoshi Hiyama, Hironobu Fujii, Shinichiro Shinzaki, Takahiro Inoue, Eri Shiraishi, Shoichiro Kawai, Manabu Araki, Yoshito Hayashi, Jumpei Kondo, Tsunekazu Mizushima, Tatsuya Kanto, Satoshi Egawa, Tsutomu Nishida, Masahiko Tsujii, Tetsuo Takehara.   

Abstract

BACKGROUND: Abrogating tolerance is a critical step in the pathogenesis of Crohn's disease (CD). T cell-anergy is one of the main mechanisms of tolerance and is regulated by the gene related to anergy in lymphocytes (GRAIL). This study investigated the expressions and regulation of GRAIL in CD and murine colitis models.
METHODS: Expressions of GRAIL mRNA and protein in CD4+ T cells were investigated in the peripheral blood and mucosal tissues of patients with CD, mice with dextran sodium salt (DSS)-induced colitis, and Il-10-deficient mice. MicroRNAs responsible for the regulation of GRAIL were examined by miRNA microarray. GRAIL-overexpressing T cells were intravenously injected in mice with DSS-induced colitis.
RESULTS: The GRAIL expression was higher in the lamina propria (LP) CD4+ T cells of CD patients than of the control subjects, while it was lower in the peripheral blood CD4+ T cells of the CD patients than of the control subjects. The GRAIL mRNA expression was lower, but the GRAIL protein expression was higher in the LP of colitic mice than that of non-colitic mice. The miRNA microarray identified miR-290-5p as an miRNA that inhibits expression of the GRAIL protein and that is highly expressed in the LP of non-colitic mice. GRAIL-expressing T cells expressed regulatory T cell markers and showed suppressive effects in murine DSS-induced colitis.
CONCLUSIONS: Our results show that expression of GRAIL is uniquely regulated by the specific miRNA in the intestinal mucosa, and suggest that GRAIL may associate with the pathophysiology of CD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356810     DOI: 10.1007/s00535-013-0923-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

2.  Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease.

Authors:  Thomas A Kraus; Lisa Toy; Lisa Chan; Joseph Childs; Lloyd Mayer
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

3.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 4.  Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance.

Authors:  Matthew J Hamilton; Scott B Snapper; Richard S Blumberg
Journal:  J Gastroenterol       Date:  2012-01-05       Impact factor: 7.527

5.  CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice.

Authors:  I Takahashi; H Kiyono; S Hamada
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

6.  The Role of MicroRNA in Inflammatory Bowel Disease.

Authors:  Sushila R Dalal; John H Kwon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11

7.  Two isoforms of otubain 1 regulate T cell anergy via GRAIL.

Authors:  Luis Soares; Christine Seroogy; Heidi Skrenta; Niroshana Anandasabapathy; Patricia Lovelace; Chan D Chung; Edgar Engleman; C Garrison Fathman
Journal:  Nat Immunol       Date:  2003-12-07       Impact factor: 25.606

8.  Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures.

Authors:  J M Schartner; A M Singh; P E Dahlberg; L Nettenstrom; C M Seroogy
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

9.  Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.

Authors:  Jack T Lin; Neil B Lineberry; Michael G Kattah; Leon L Su; Paul J Utz; C Garrison Fathman; Linda Wu
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 10.  Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases.

Authors:  Vanessa Leone; Eugene B Chang; Suzanne Devkota
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

View more
  4 in total

1.  Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis.

Authors:  Eri Shiraishi; Hideki Iijima; Shinichiro Shinzaki; Sachiko Nakajima; Takahiro Inoue; Satoshi Hiyama; Shoichiro Kawai; Manabu Araki; Toshio Yamaguchi; Yoshito Hayashi; Hironobu Fujii; Tsutomu Nishida; Masahiko Tsujii; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2015-08-28       Impact factor: 7.527

2.  Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma.

Authors:  Chuan-Yuan Wei; Meng-Xuan Zhu; Yan-Wen Yang; Peng-Fei Zhang; Xuan Yang; Rui Peng; Chao Gao; Jia-Cheng Lu; Lu Wang; Xin-Yi Deng; Nan-Hang Lu; Fa-Zhi Qi; Jian-Ying Gu
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

3.  Interleukin (IL)-1β Is a Strong Inducer of IL-36γ Expression in Human Colonic Myofibroblasts.

Authors:  Kenichiro Takahashi; Atsushi Nishida; Makoto Shioya; Hirotsugu Imaeda; Shigeki Bamba; Osamu Inatomi; Tomoharu Shimizu; Katsuyuki Kitoh; Akira Andoh
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

Review 4.  The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Authors:  Min Zou; Qi-Shan Zeng; Jiao Nie; Jia-Hui Yang; Zhen-Yi Luo; Hua-Tian Gan
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.